Intracellular and Plasma Pharmacokinetics of Saquinavir-Ritonavir, Administered at 1,600/100 Milligrams Once Daily in Human Immunodeficiency Virus-Infected Patients

Ritonavir-boosted saquinavir (SQV/r) is currently licensed as a twice-daily regimen. Reducing the pill burden with once-daily dosing may improve adherence. Intracellular concentrations of drugs must be related to the clinical efficacy of protease inhibitors. The aims of the study were to determine t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ford, Jennifer, Boffito, Marta, Wildfire, Adrian, Hill, Andrew, Back, David, Khoo, Saye, Nelson, Mark, Moyle, Graeme, Gazzard, Brian, Pozniak, Anton
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2004
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC434222/
https://ncbi.nlm.nih.gov/pubmed/15215085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.7.2388-2393.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados